Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Optimized intraorbital optic nerve exposure: a translational surgical paradigm for neural regeneration in rat model.

Zhu H., Li G., Zhu M., Ma J., Shen P., Zhang S.

Animal Study on Face & Skin, published in Int Ophthalmol (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Int Ophthalmol (2025)
Country
Netherlands
Reported sample size
—
Source database
PubMed
PMID
40504418
DOI
10.1007/s10792-025-03621-3

Abstract (original English)

To establish a standardized microsurgical protocol for atraumatic exposure of extended intraorbital optic nerve segments in rat models, enabling precision interventions in neural regeneration research. Aseptic surgical procedures were performed on anesthetized Sprague-Dawley rats, involving three critical steps: (1) precision skin incision with bilateral silk suture retraction, (2) meticulous periorbital adipose tissue dissection, and (3) atraumatic full-length optic nerve exposure. Post-exposure interventions comprised optic nerve crush (ONC) modeling, intrasheath injection, scaffold and hydrogel implantation. Validation encompassed functional (Functional Visual Evoked Potentials, FVEP), vascular (Fluorescein Fundus Angiography, FFA), and cellular (RGC density and axonal integrity via cholera toxin B subunit (CTB) anterograde tracing) assesments. The approach reliably exposed 5-mm intraorbital optic nerve segments (4.96 ± 0.13 mm) with intact vasculature (FFA-confirmed perfusion). Complete ONC validation was demonstrated through three principal findings: (a) Complete FVEP signal ablation (Ampliude P1 (OS/OD) pre-operation 1.05 ± 0.19, sham 1.00 ± 0.06, ONC 0.03 ± 0.02, * p < 0.05), (b) Progressive RGC loss quantified by CTB anterograde signal attenuation (Week 1: 1496.7 ± 186.3; Week 2: 146.3 ± 13.0; Week 3: 110.0 ± 12.4;Week 4: 78.75 ± 5.1, * p < 0.05), and (c) Axonal discont

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsRats, Sprague-DawleyNerve RegenerationRatsOptic Nerve InjuriesDisease Models, AnimalOptic NerveEvoked Potentials, VisualMicrosurgeryRetinal Ganglion Cells

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research